Nitromethaqualone

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Nitromethaqualone
Nitromethaqualone.svg
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H13N3O4
Molar mass311.29 g·mol−1
3D model (JSmol)

Nitromethaqualone[1] is an analogue of methaqualone that has similar sedative and hypnotic properties.[2] It is significantly more potent (10x) compared to the parent compound; the typical dose is approximately 25 mg.[3] However, the aromatic nitro group is metabolised to the corresponding aniline, which proved to be a mutagen;[3] as a consequence, nitromethaqualone was not developed further due to toxicity concerns.

References[edit]

  1. ^ US patent 3162634, Klosa, J. (Berlin, Germany), "2-Methyl-3-(2'-methyl-3'-chlorphenyl)-quinazolone-(4)", issued 1964-12-22 
  2. ^ Szirmai, A. (1963). "(title in German)" [Pharmacological and Therapeutic Studies with a New Quinazolone Derivative, Nitromethaqualone]. Therapeutische Umschau (in German). 20: 542–546. PMID 14101319.
  3. ^ a b van Boven, M.; Daenens, P. (1982). "Biotransformation and Excretion of Nitromethaqualone in Rats and Humans". Journal of Pharmaceutical Sciences. 71 (10): 1152–1157. doi:10.1002/jps.2600711019. PMID 7143214.